• Aucun résultat trouvé

What is the role of relatives in treatment choice of patients with advanced chronic kidney disease?

N/A
N/A
Protected

Academic year: 2021

Partager "What is the role of relatives in treatment choice of patients with advanced chronic kidney disease?"

Copied!
3
0
0

Texte intégral

(1)

HAL Id: hal-03121046

https://hal.archives-ouvertes.fr/hal-03121046

Submitted on 26 Jan 2021

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

What is the role of relatives in treatment choice of patients with advanced chronic kidney disease?

Lucile Montalescot, Karine Legrand, Géraldine Dorard, Carole Ayav, Serge Briançon, Christian Combe, Benedicte Stengel, Aurélie Untas

To cite this version:

Lucile Montalescot, Karine Legrand, Géraldine Dorard, Carole Ayav, Serge Briançon, et al.. What is the role of relatives in treatment choice of patients with advanced chronic kidney disease?. European Health Psychology Society, Aug 2018, Padova, Italy. �10.13140/RG.2.2.19163.87849�. �hal-03121046�

(2)

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/323557393

What is the role of relatives in treatment choice of patients with advanced chronic kidney disease?

Poster · August 2017 DOI: 10.13140/RG.2.2.19163.87849 CITATIONS 0 READS 56 8 authors, including:

Some of the authors of this publication are also working on these related projects:

TherafamView project

Contextual factors related to fine-scale geographic variations of renal replacement therapy incidence in north-eastern FranceView project Lucile Montalescot

Université de Nîmes

8 PUBLICATIONS   41 CITATIONS    SEE PROFILE

Karine Legrand

Centre Hospitalier Universitaire de Nancy

76 PUBLICATIONS   162 CITATIONS    SEE PROFILE Géraldine Dorard Paris Descartes, CPSC 40 PUBLICATIONS   262 CITATIONS    SEE PROFILE Carole Ayav

Centre Hospitalier Universitaire de Nancy

120 PUBLICATIONS   791 CITATIONS    SEE PROFILE

All content following this page was uploaded by Lucile Montalescot on 05 March 2018.

(3)

What is the role of relatives

in treatment choice of patients

with advanced chronic kidney disease?

Treatment choice between transplantation, dialysis or conservative treatment is a stressful time for patients reaching end-stage

chronic kidney disease (CKD) (Visser et al., 2009).

Clinical guidelines advise nephrologists to proceed to a shared decision-making regarding this treatment choice (Covic et al., 2010).However, patients often report an “illusion of choice” (Morton et al., 2010).

Family plays an important role during the decision-making process. Indeed, patients often consider the consequences their potential

treatment could have on their family and value their relatives’ opinion (Morton et al., 2010).

Lucile Montalescot

1

, Karine Legrand

2

, Géraldine Dorard

1

, Carole Loos-Ayav

2

,

Serge Briançon

2

, Christian Combe

3

, Bénédicte Stengel

4

, Aurélie Untas

1

1 Laboratory of Psychopathology and Health Processes-EA 4057, Paris Descartes University, Sorbonne Paris Cité, France; 2 Clinical Epidemiology, Inserm CIC-EC 1433, CHU de

Nancy, Vandoeuvre-lès-Nancy, France; 3 Department of Nephrology Transplantation Dialysis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Inserm, U1026,

Bordeaux University, France; 4 Inserm, UMR 1018, CESP Centre for Research in Epidemiology and Population Health, Team 5, Renal and Cardiovascular Epidemiology, Paris

Sud University, Villejuif, France.

The aim of this study is to explore the role of family members in the

treatment decision-making process in advanced CKD

Recruitment is underway. This study will allow us to:

→ Better understand how patients make their

treatment choice

→ Formulate recommendations to the medical staff to

better help the patients and their relatives

2 Years

Procedure

Sample and Measures

3000

patients

3000

relatives

Analyses

Illness experience Family communication Role in decision-making • Depression (CES-D)Anxiety (HADS)

Quality of life (KDQOL-SFTM, SF-12)Satisfaction with care (CAHPS)

Family relationships (FRI)Assertiveness (NEO-PI-R)

Relatives’ influence on treatment

decision

Illness perception (Brief-IPQ)*

Quantitative analyses: Cluster analyses, variance analyses

and Structural Equation Modeling according to the Actor and Partner Interdependence Model (APIM)

Qualitative analyses: Lexicometric analyses and

Interpretative Phenomenological Analysis on subgroups

Semi-structured interviews - Dialysis - Transplantation - Conservative treatment Advanced CKD Advanced CKD

Covic, A., Bammens, B., Lobbedez, T., Segall, L., Heimbürger, O., Van Biesen, W., ... & Vanholder, R. (2010). Educating end-stage renal disease patients on dialysis modality selection. NDT plus, 3(3), 225-233; Morton, R., Tong, A., Howard, K., Snelling, P., Webster, A. (2010). The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. British Medical Journal, 19 (340) ; Visser, A., Dijkstra, G. J., Kuiper, D., de Jong, P. E., Franssen, C. F., Gansevoort, R. T., ... & Reijneveld, S. A. (2009). Accepting or

declining dialysis: Considerations taken into account by elderly patients with end-stage renal diseas. JN journal of nephrology, 11(6), 794.

Corresponding author: lucile.montalescot@gmail.com

*For relatives only

View publication stats View publication stats

Références

Documents relatifs

Although the exact serum (S K ) or plasma potassium (P K ) concentration associated with increased mortality remains controversial, growing evidence suggests that in patients with

some as “a first dialysis without a permanent access device in place.” 1 In France and in this study, EDS is defined as a first dialysis session started within 24 hours after

Conclusions: The quality of life of haemodialysis adolescents, and mainly the dimensions of leisure activities, physical well-being, relationships with friends and energy-vitality,

Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P, International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group (2005) International

Lectura e interpretación de planos, bosquejos de obra, cálculo de costos y elaboración de presupuestos, orden de trabajo, uso de equipo de protección personal, materiales

• We recommend that children with stage 3–5 chronic kidney disease (CKD) or on dialysis aged above 6 months should be candidates for GH therapy if they have persistent growth

Conclusion: Many patients referred with the hypothesis of hyperplasia of a subtotally resected parathyroid gland or autograft were found to harbour a supernumerary parathyroid